[1]
S. Saseedharan, P. Aneja, A. Chowti, K. Debnath, K. D. Mehta, and P. Sonone, “Efficacy and safety of intravenous and/or oral levonadifloxacin in the management of secondary bacterial pulmonary infections in COVID-19 patients: findings of a retrospective, real-world, multi-center study”, Int J Res Med Sci, vol. 9, no. 10, pp. 2933–2939, Sep. 2021.